Log In

Forgot Password?

OR

Not a member? Continue as a nonmember.

Become a Member

By becoming a member of the AAN, you can receive exclusive information to help you at every stage of your career. Benefits include:

Join Now See All Benefits

Loading... please wait

2024 Annual Meeting | H104 - Lessons Learned from Multi-center Trial Submission (Research Hub)

Monday 04/15/24
01:00 PM - 01:30 PM MDT Add To Calendar
Colorado Convention Center | Exhibit Hall B-E
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Hubs (Research)
Gregory S. Day, MD, MSc, FAAN
General Neurology, Education, Research, and Methodology
Submitting a multi-center trial grant can be time consuming and confusing. This interactive session will offer practical tips and solutions for trial submission, based on the presenter's personal experience developing, opening, and conducting the NIH-funded ExTINGUISH Trial for NMDAR encephalitis.
No CME available
Medical Knowledge, Systems-based Practice, Quality Improvement
Intermediate
Advanced Practice Provider
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Neurohospitalist, Coordinator
Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:30 PM MDT Speaker Lessons Learned from Multi-center Trial Submission
Gregory S. Day, MD, MSc, FAAN
Faculty Disclosures
Gregory S. Day, MD, MSc, FAAN Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parabon Nanolabs. The institution of Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eli Lilly. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys Therapeutics. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for DynaMed (EBSCO Health). Dr. Day has stock in ANI Pharmaceuticals. The institution of Dr. Day has received research support from National Institutes of Health / NIA. The institution of Dr. Day has received research support from Chan Zuckerberg Initiative. The institution of Dr. Day has received research support from Alzheimer's Association. The institution of Dr. Day has received research support from National Institutes of Health / NINDS. The institution of Dr. Day has received research support from Horizon Therapeutics. The institution of Dr. Day has received research support from AVID Radiopharmaceuticals. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Presenter at Annual Meeting (CME) with American Academy of Neurology. Dr. Day has received personal compensation in the range of $500-$4,999 for serving as a Content Development (CME) with PeerView, Inc. Dr. Day has received personal compensation in the range of $5,000-$9,999 for serving as a Content Development (CME) with Continuing Education, Inc. Dr. Day has a non-compensated relationship as a Clinical Director with AntiNMDA Receptor Encephalitis Foundation that is relevant to AAN interests or activities.